Clinical Evaluation of the Cook Advance Enforcer 35 Focal-Force PTA Balloon Catheter for Treatment of Hemodialysis Fistula Stenoses: A Feasibility Study

Holden, Andrew; Hill, Andrew; Buckley, Brendan; Connor, Brigid; Semple, David; Merrilees, Stephen; Marsh, Emma; Alfahad, Aws; Iyer, Ram

doi:10.1016/j.jvir.2018.08.015

Cited by 2 publications

(2 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…β2-MG is a small protein that can be detected in a variety of body fluids, such as urine, blood and cerebrospinal fluid. Many investigations have indicated that serum β2-MG level can be used as an indicator of renal function [20,21]. β2-MG has a small molecular weight and is mostly reabsorbed and catabolized by renal tubules.…”

Section: Discussionmentioning

confidence: 99%

Effect of the combination of percutaneous transluminal angioplasty and pharmacological thrombolysis on hemodialysis patients

Yang¹,

Tang²,

Zhong³

2022

Trop. J. Pharm Res

View full text Add to dashboard Cite

Purpose: To examine the efficacy of percutaneous transluminal angioplasty (PTA), combined withpharmacologic thrombolysis (PT) on thrombosis of autologous arteriovenous fistulas (AVFs),inflammatory factors, and β2 microglobulin (β2-MG) levels in hemodialysis patients.Methods: Seventy-eight patients with AVF thrombosis allocated randomly into a control group (CG) received PTA, and a study group (SG) received PTA combined with PT (n = 39 in each). The patency, vascular condition, inflammatory factors, viz, interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP)), β2-MG levels, vascular-related factors (VEGF-A and MCP-1), complications, and quality of life were determined.Results: At three and six months after surgery, t SG exhibited a higher vascular patency than CG (p <0.05). Serum levels of IL-6, hs-CRP, β2-MG, VEGF-A, and MCP-1 of t SG were lower than those of CG(p < 0.05). The SG showed higher cross-sectional area, inner diameter at the site of fistula, and better quality of life scores than CG (p < 0.05).Conclusion: The combination of PTA and PT enhances efficacy, increases vascular patency, reduces inflammatory response, lowers the level of β2-MG, and improves quality of life in patients with AVFs without increasing complications. Thus, the combination treatment has potentials for the management of hemodialysis patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of the combination of percutaneous transluminal angioplasty and pharmacological thrombolysis on hemodialysis patients

Yang¹,

Tang²,

Zhong³

2022

Trop. J. Pharm Res

View full text Add to dashboard Cite

show abstract

“…These plastic elements are incorporated during a single extrusion process, thus avoiding seams or joints, and providing focal force upon inflation to aid in lesion dilation. A single-center prospective feasibility study explored this scoring balloon's short-term performance to reduce stenosis of a mature native arteriovenous fistula (AVF) ( 11 ). Only one patient required an adjunctive treatment.…”

Section: Prevention Of Dissection and Recoilmentioning

confidence: 99%

Vessel Preparation Is Essential to Optimize Endovascular Therapy of Infrainguinal Lesions

Saucy

Probst

Trunfio

2020

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

Symptomatic peripheral arterial disease management involves medical treatment and interventional procedures. Intermittent claudication and critical limb threatened ischemia (CLTI) should be individually considered with specific outcomes and procedures. When intervention is required, an endovascular approach is usually the first-line option. Plain balloon angioplasty was previously used to dilate clinically significant femoropopliteal lesions with variable results. However, over recent years, the use of self-expanding nitinol stents has enabled treatment of long lesions, yielding significantly improved clinical results. Drug-eluting technology has also exhibited a capacity to limit in-stent restenosis and to drive target revascularization. Nevertheless, calcifications and elastic recoil of the arterial wall remain risk factors for early restenosis and failure. Therefore, vessel preparation using specific devices is required to modify vessel compliance and debulk obstructive calcification. In this short review, we provide an overview of the options for gaining lumen before stenting or dilation using drug-coated balloons.

show abstract

Clinical Evaluation of the Cook Advance Enforcer 35 Focal-Force PTA Balloon Catheter for Treatment of Hemodialysis Fistula Stenoses: A Feasibility Study

Cited by 2 publications

References 17 publications

Effect of the combination of percutaneous transluminal angioplasty and pharmacological thrombolysis on hemodialysis patients

Effect of the combination of percutaneous transluminal angioplasty and pharmacological thrombolysis on hemodialysis patients

Vessel Preparation Is Essential to Optimize Endovascular Therapy of Infrainguinal Lesions

Contact Info

Product

Resources

About